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Abstract: For clinical isolates of Haemophilus influenzae and Streptococcus pneumoniae in
Japan (356 and 179 strains, respectively) and in the Philippines (98 and 59 strains, respec-
tively), minimum inhibitory concentrations (MICs) of ampicillin, cefazolin, cefotiam, ceftizox-
im, ofloxacin, erythromycin, and minocycline were examined. The rates of β-lactamase pro-
ducing H. influenzae were 17.7% (63/356) in Japan and 2.0% (2/98) in the Philippines, and
all of these strains were ampicillin MICs 〓1.56 ugml-1. In addition, 5 strains in Japan that
lacked β-lactamase activity were also less susceptible to ampicillin. Among the an-
timicrobials tested, ceftizoxim was the most active against H. influenzae in both countries
(MICs 〓0.2 ugml-1). Five strains of S. pneumoniae in Japan were relatively resistant to am-
picillin (MIC=0.1 ugml-1), whereas there were no such strains among isolates in the Philip-
pines. Forty strains (22.3%) and 108 strains (60.3%) among S. pneumoniae in Japan ex-
hibited erythromycin MICs 〓0.2 ugml-1 and minocycline MICs 〓1.56 ugml-1, respective-
ly. In contrast, all isolates in the Philippines were erythromycin MICs 〓0.05 ugml-1 and
minocycline MICs 〓0.39 ugml-1. Present study indicates that H. influenzae and S.
pneumoniae in the Philippines remained still susceptible to the antimicrobials tested except
for 2 β-lactamase-positive, ampicillin-resistant H. influenzae, whereas ampicillin-resistant H.
influenzae mediated by β-lactamase or non-β-lactamase mechanisms and ampicillin-,
erythromycin- or minocycline-resistant S. pneumoniae were included among isolates in
Japan.
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INTRODUCTION
Haemophilus influenzae (Everett et al, 1977; McGowan et al., 1974) and Streptococcus
pneumoniae (Davies and Kumaratne 1988; Gillespie 1989) were important bacterial pathogens
causing systemic infections, such as sepsis and meningitis, in addition to respiratory tract in-
fections. Recently, increase of prevalence of resistance in H. tnfluenzae (Istre et al., 1984;
Kayser et al., 1990) and S. pneumoniae (Baquero et al., 1991; Ridgway et al., 1991; Spika et
al., 1991) have been clinically becoming problems. It is important to monitor for the
prevalence of antimicrobial resistance in each country for treating invasive, life-threatening in-
fections caused by these organisms. Surveys of the prevalence of resistance in H. influenzae
(Kayser et al., 1990; Doern et al., 1986; Doern et al., 1988; Powell et al., 1987) and S.
pneumoniae (Baquero et al., 1991; Spika et al., 1991) have been carried out in several coun-
tries.
In this study, antimicrobial susceptibility of clinical isolates of H. influenzae and S.
pneumoniae in Japan and in the Philippines was investigated, and the prevalence of resistance
of these organisms was compared. The rate of β-lactamase producing strains in･ H. influenzae
and the correlation of resistance between erythromycin (EM) and minocycline (MINO) in S.
pneumoniae were also examined.
MATERIALS AND METHODS
clinical isolates. For isolates in Japan, 356 strains of H. influenzae and 179 strains of S.
pneumoniae collected between December 1986 and November 1987 at Nagasaki University
Hospital, Nagasaki, Japan, were used. For isolates in the Philippines, 98 strains of H. mfluen-
zae and 59 strains of S. pneumoniae collected between December 1984 and November 1985 at
Research Institute for Tropical Medicine, Manila, the Philippines, were used. All isolates
were recovered from different patients. The isolates in the Philippines were sent to Nagasaki
university Hospital. After confirmation of identity, antimicrobial susceptibility testing for
isolates in both countries was performed at one time at Nagasaki Tniversity Hospital.
Antibiotics. The following 7 antimicrobial agents were obtained from the indicated sources:
ampicillin (ABPC), Meiji Seika Kaisha, Ltd., Tokyo, Japan; cefazolin (CEZ), Fujisawa Phar-
maceutical Co., Ltd., Tokyo, Japan; cefotiam (CTM), Takeda Chemical Industries Ltd.,
osaka, Japan; ceftizoxime (CZX), Fujisawa; ofloxacin (OFLX), Daiichi Pharm. Co., Ltd.,
Tokyo, Japan; EM, Dainippon Pharm. Co., Ltd., Osaka, Japan;叩NO, Lederle (Japan) Ltd.,
Tokyo, Japan.
Antimicrobial susceptibility testing. Minimum inhibitory concentrations (MICs) of an-
tibiotics against H. influenzae and S. pneumoniae were determined by broth microdilution
method using serial twofold dilutions of an individual antibiotic (Sahm and Washington II
1991). Test medium consisted of Mueller-Hinton broth (Difco Laboratories, Detroit, Mich.),
50mg of nicotinamide adenine dinucleotide (Sigma Chemical Co., St. Louis, Mo.) per liter, 50
ml of heat-inactivated fetal calf serum (Nakarai Chemical Co., Ltd., Tokyo, Japan) per liter,
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30ml of lysed horse blood (Nissei kagaku Co., Ltd., Tokyo, Japan) per liter, 3g of yeast ex-
tract (Oxoid, Ltd･ Basingstoke, Hampshire, UK) per liter, 25mg of magnesium per liter, and
50mg of calcium per liter. The 7 antimicrobial agents were examined against all study
isolates at concentrations ranging from 0.025 to 50 ugm卜1. Bacteria were inoculated to ob-
tain a final concentration of approximately 105 CFUml-　and test plates were incubated for
20 to 24h at 35C in ambient air. Then, wells were examined macroscopically for evidence of
growth. The MIC was defined as the lowest concentration of antimicrobial agent tested
which inhibited visible growth of bacteria. Strains of H. influenzae ATCC 35056,
Pseudomonas aeruginosa ATCC 27853, Escherichia coli ATCC 25922, and Staphylococcus
aureus ATCC 29213 for which the MICs of the antimicrobial agents were known, were used
as control of antimicrobial susceptibility testing.
Detection of β-lactamase. β-lactamase production in H. influenzae was determined by in-
cubating suspensions of each strain with chromogenic cephalosporin (nitrocefin) at room
temperature for 10 mm and visually assessing color development (O'Callaghan et al., 1972).
RESULTS
MICs of ABPC, CEZ, CTM, and CZX against H. influenzae. The in vitro activities of
4 β-lactam antibiotics against 356 strains in Japan and 98 strains in the Philippines were
shown in Table 1. MICs for 50% of strains (MICSOs) of ABPC, CEZ, CTM, and CZX for
strains in Japan were respectively 0.39, 6.25, 0.78, and 〓0.025 ugm卜:, whereas MICSOs for
strains in the Philippines were 0.2, 3.13, 0.78, and 〓0.025 ugml-1, respectively. Concerning
the distribution of MICs of ABPC, there was a distinct difference between Japan and the
Philippines. Only 2 strains in the Philippines (2.0%) were resistant to ABPC (MICs of 12.5
ugml"1 and 25 ugml-1), whereas 50 strains in Japan (14.0%) exhibited ABPC MICs 〓6.25
ugml i. Among ,8-lactam antimicrobial agents tested, CZX was the most active against H. in-
fluenzae in both countries. All 98 strains in the Philippines and 343 strains in Japan (96.3%)
were inhibited by CZX at a concentration of 0.025 ugml-1, but remaining 13 strains isolated
in Japan exhibited resistance to CZX at 0.05 ugml-1 (8 strains), 0.1 ugml- (4 strains), and
0.2 ugml-1 (1 strain) of CZX, respectively.
MICs of ABPC for beta-lactamase-positive and -negative strains of H. in伽enzae.
The rate of β-lactamase production among strains in Japan was 17.7% (63/356 strains). In
contrast, 2.0% of strains (2/98 strains) in the Philippines produced β-lactamase (Table 2). All
of these β-Iactamase producing strains were ABPC叫cs 〓1.56 ugm卜x. In addition, 5
strains (1.4%) in Japan that lacked β-lactamase activity showed ABPC MICs 〓1.56 ugml-1.
These 5 strains were also less susceptible to CZX; CZX MICs of 0.2 ugml-1 (1 strain), 0.1
ugml"1 (3 strains), and 〓0.025 ugml- (1 strain). However, all 96 strains in the Philippines
that lacked β-lactamase activity were ABPC MICs 〓0.39 ugml｣.
MICs of OFLX, EM, and MINO against H. influenzae. The in vitro activities of 3
other classes of antimicrobial agents against H. influenzae were shown in Table 3. In MICSOs
of OFLX, EM, and MINO, there were no differences between strains in Japan and in the
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Table 2. MICs of ABPC for /3-lactamase-positive and -negative strains of H. inflwnzae in Japan (356
strains) and in the Philippines (98 strains)
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Philippines (〓0.025, 3.13, and 0.2 ugml- respectively). However, 2 strains in Japan were ful-
ly resistant to MINO (MICs of 6.25 ugml-　and 12.5 ugml-1), although all 98 strains in the
philippines were MINO MICs 〓0.78 ugml~1.
MICs of ABPC, CEZ, CTM, and CZX against 8. pneumoniae. The in vitro activities of
4 β-lactam antibiotics against 179 strains in Japan and 59 strains in the Philippines were
shown in Table 4. In MICSOs of ABPC, CEZ, CTM, and CZX, there were no differences bet-
ween strains in Japan and in the Philippines (〓0.025, 0.1, 0.1, and 0.05 ugml-1, respective-
ly). Among these β-lactam antimicrobial agents, ABPC was the most active against S.
pneumomae isolated in both countries. However, 5 strains in Japan (2.89及b) were relatively
resistant to ABPC (MIC-0.1 ugml-1).
MICs of OFLX, EM, and MINO against S. pneumoniae. The in vitro activities of 3
other classes of antimicrobial agents were shown in Table 5. MICSOs of OFLX, EM, and
Table 4. MICs of ABPC, CEZ, CTM, and CZX for S. pneumoniae in Japan (179 strains) and in the Philip-
pines (59 strains)
Country
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Table 5. MICs of OFLX, EM, and MINO for S. pneumoniae in Japan (179 strains) and in the Philippines
(59 strains)
Country










aMIC50 of each antibiotic was indicated by underline.
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MINO for strains in Japan were respectively 1.56, 0.05, and 6.25 ugml"1, whereas MIC50s
for strains in the Philippines were 1.56, 0.05, and 0.2 ugml- , respectively. Among isolates in
Japan, 40 strains (22.3%) were EM MICs 〓0.2 ugml-1 and 108 strains (60.3%) were MINO
MICs 〓1.56 ugm卜　However, all isolates in the Philippines were EM MICs 〓0.05 ugml-1
and MINO MICs 〓0.39 ugml~1.
correlation of MICs between MINO and EM for S. pneumoniae. Strains of S.
pneumoniae were divided into 4 groups (A-D) by MINO MICs <1.56 or 〓1.56 ugml"1 and
EM MICs <0.2 or >0.2 ugml-1 as shown in Figure 1 (group A, MINO MICs <1.56 ugml-i
and EM MICs <0.2 ugml-!; B, MINO MICs 〓1.56 ugml-1 and EM MICs <0.2 ugml~^ c,
MINO MICs 〓1.56 ugml-1 and EM MICs 〓0.2 ugml-1; D, MINO MICs <1.56 ugml-1 and
EM MICs >0.2 ugml-1 ). All isolates in the Philippines belonged to group A. In contrast,
the strains in Japan were more variable. Among 108 strains in Japan (MINO MICs 〓1.56
ugml-1), 38 strains (35.2%, 38/108 strains) were EM MICs 〓0･2 ugml"1 (group C), whereas
among 71 strains (MINO MICs <1.56 ugml"1), only 2 strains (2.8%, 2/71 sヒrams) showed
































Fig. 1. Correlation of MICs of MINO and EM for S. pneumoniae. Each strain of
s. pneumoniae in Japan (179 strains) and in the Philippines (59 strains) was plot-
ted by MIC values (ugml-1) of MINO and EM.
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DISCUSSION
The rates of ^-lactamase producing strains of H, influenzae in Japan and in the Philip-
pines were 17.7% (63/356 strains) and 2.0% (2/98 strains), respectively. The vast majority of
β-lactamase produced by H. influenzae has been known to be TEM-type β-Iactamase (Heffron
et al., 1975) and is mediated by genes located on a conjugative R-plasmid (Elwell et al., 1975;
Sykes et al., 1975). From the first report of /3-lactamase producing H. influenzae in 1974
(Khan et al., 1974) series of surveillances in prevalence of /3-lactamase-positive strains have
been carried out in several countries. In nationwide studies in the United States, the rates of
/3-lactamase producing strains of H. influenzae in 1984 (Doern et al., 1986) and in 1986
(Doern et al., 1988) were 15.2% and 20.0%, respectively. European collaborative studies have
shown that 10.9% in 1986 (Machka et al, 1988) and 9.1% in 1988/89 (Kayser et al., 1990)
produced β-lactamase. In the present study, the prevalence of β-lactamase producing strains
in the Philippines remained still at low levels compared with the rates in the United States
and Europe, although the prevalence in Japan was similar to that seen in the United States
performed in 1986.
The problem of ABPC resistance in H. influenzae is complicated by descriptions of
clinical isolates that are resistant to ABPC by mechanisms other than the production of /3-lac-
tamase (Mendelman et al., 1984; Offit et al., 1982). Parr and Bryan (1984) have reported that
alteration in the binding capacity of penicillin-binding proteins (PBPs) of H. influenzae was
correlated with the β-lactam resistance of this organism. Among H. influenzae in Japan that
lacked β-lactamase production, 5 strains (1.4%) showed ABPC MICs 〓1.56 ugml｣. These 5
strains were also less susceptible to CZX. On the other hand, all isolates in the Philippines
that lacked β-lactamase activity were susceptible to ABPC, which were inhibited by ABPC
concentration of 0.39 ugml-　Recent increasing use of new β-Iactams, most of which are
stable in the presence of β-lactamase of H. influenzae, is likely to increase selective pressure
on ABPC-resistant strains mediated by such nonサIactamase mechanisms.
Five strains of S. pneumoniae in Japan were relatively resistant to ABPC (MIC-0.1
ugm卜L), whereas growth of all isolates in the Philippines were inhibited by ABPC concentra-
tion of 0.05 ugml *. From the report of S. pneumoniae with greater resistance to penicillin
(MIC-4 ugml-1) in 1977 (Appelbaum et al., 1977), several surveillances for resistant S.
pneumon由e have been carried out. Recent study in the United States has reported that 5% of
isolates were ABPC MICs 〓0.1 ugml-1 (Spika et al, 1991). Other report in Europe has
shown that over 25% of isolates in Spain, Hungary, and Poland were penicillin MICs >0.1
ugml-1 (Baquero et al., 1991). In Spain, a close relationship has been found between the year-
ly rate of aminopenicillin consumption and penicillin resistance (Baquero et al., 1991). The
development of resistance to penicillin by S. pneumoniae has been also reported to be
associated with changes in the affinity and molecular size of PBPs (Handwerger and Tomasz
1986; Jabes et al., 1989).
All isolates of S. ♪neumoniae in the Philippines were EM MICs 〓0.05 ugml-1 and
MINO MICs 〓0.39 ugml l. In contrast, among 179 strains of 5. pneumoniae in Japan, 40
50
strains (22.3%) were EM MICs 〓0.2 ugml~　and 108 strains (60.3%) were MINO MICs
〓1.56 ugml-1 (Table 5). As血own in Fig. 1, over 35% of MINO-resistant strains were
simultaneously EM-resistant, whereas only 2.8% of MINO-sensitive strains were EM-resis-
tant. These results suggest that acquisition of MINO resistance may be prerequisite to
development of EM resistance, at least, for S. pneumoniae tested in this study. With respect
to the mechanisms of development of EM and MINO resistance in S. pneumomae, a con-
jugative transposon carrying resistance genes for these antibiotics has been described (Cour-
valin and Carlier 1986). Further studies were required to elucidate the molecular mechanisms
of cross-resistance between EM and MINO in S. pneumomae.
In conclusion, H. influenzae and S.タnβumoniae in the philippines remained still suscepti-
ble to the antimicrobials tested except for 2 strains of β-lactamase-positive, ABPC-resistant
H. influenzae, whereas ABPC-resistant H. influenzae mediated by β-lactamase or non-/3-lac-
tamase mechanisms and ABPC-, MINO- or EM-resistant S. pneumomae were included among
isolates in Japan. Continuous surveillances to monitor for the prevalence of resistance to an-
timicrobials in H. influenzae and S. pneumoniae were needed.
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